Submission of outcome of 31st AGM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd (formerly Trimurthi Limited) held its 31st AGM on September 19, 2025 via video conferencing, chaired by Whole-time Director Mr. Venkateshwarlu Pulluru. 81 members attended the meeting, which concluded at 3:47 PM. Shareholders transacted 9 items, including adoption of FY2024-25 audited financial statements and re-appointment of Mr. Jivamohan Divakar Valluri as Non-Executive Director. Key special resolutions approved include increasing the company's borrowing limit under Section 180(1)(c), creation of mortgage/charge on company assets under Section 180(1)(a), and authority for investments, loans, and guarantees under Section 186. The meeting also approved transactions under Section 185 and appointed Ms. Mayuri Baidya as Independent Director and Mr. Gattu Gnana Prakash as Non-Executive Non-Independent Director. E-voting results will be announced within 48 hours based on the scrutinizer's report.
The cluster of special resolutions expanding borrowing capacity, asset charging powers, and inter-company loan/investment authority suggests the company may be preparing for significant capital raising, expansion, or strategic transactions. New board appointments indicate governance restructuring. No immediate share-price catalyst, but shareholders should watch for the e-voting results and any follow-up announcements on debt or acquisitions.